BLK
BlackRock, Inc.
BLK trails on the overall score without a compensating advantage in the available component scores.
CRBG
Corebridge Financial, Inc.
CRBG has the edge over BLK overall, supported by stronger valuation and stronger modeled upside.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
CRBG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CRBG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRBG.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
CRBG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.7x | $35.97 | — |
| Cheap | 7.4x | $33.58 | -6.6% |
| Current | 8x | $35.97 | — |
| Fair | 9.6x | $43.16 | +20% |
| Expensive | 29x | $130 | +262% |
Historical ranges are pointers, not guarantees.
CRBG has the edge over BLK in the historical PE scenario, which offers more potential upside but is not a forecast.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
CRBG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CRBG's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK earned $43.87 per share over the past year, up 11% from the year before.
CRBG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.39 | +19% |
| Q3 2026 | $4.51 | +178% |
| Q2 2026 | $1.56 | +$2.23 |
| Q1 2026 | $0.40 | -64% |
| Q4 2025 | -$0.68 | -118% |
| Q3 2025 | $1.62 | +$3.69 |
| Q2 2025 | -$0.67 | -121% |
| Q1 2025 | $1.12 | -71% |
| Q4 2024 | $3.72 | +118% |
CRBG earned $4.51 per share over the past year, up 178% from the year before.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over CRBG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
CRBG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.2B | +14% |
| Q2 2026 | $3.9B | +43% |
| Q1 2026 | $4B | +10% |
| Q4 2025 | $6.8B | +2.2% |
| Q3 2025 | $5.4B | +107% |
| Q2 2025 | $2.7B | -26% |
| Q1 2025 | $3.6B | -38% |
| Q4 2024 | $6.6B | +97% |
CRBG's revenue has grown year over year for five quarters in a row: $6.2B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +39 points |
| Q2 2026 | 1.3% | +24 points |
| Q1 2026 | 2.5% | +27 points |
| Q4 2025 | 14% | -30 points |
| Q3 2025 | -0.8% | +60 points |
| Q2 2025 | -22% | -35 points |
| Q1 2025 | -24% | -41 points |
| Q4 2024 | 44% | +97 points |
CRBG has the edge over BLK on profitability, with a higher operating margin.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over CRBG on cash flow, with more consistent year-over-year improvement.
CRBG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $605M | +2421% |
| Q2 2026 | -$44M | +$215M |
| Q1 2026 | -$9M | -102% |
| Q4 2025 | $1.9B | +27% |
| Q3 2025 | $24M | -71% |
| Q2 2025 | -$259M | -$250M |
| Q1 2025 | $375M | -37% |
| Q4 2024 | $1.5B | +93% |
CRBG's free cash flow was $2.4B over the past year, up 50% from the year before. Free cash flow isn't a meaningful measure for financial services companies like CRBG.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has 165M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
CRBG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -7M shares |
| 1 year | -17% | -93.4M shares |
| 3 years | -30% | -194M shares |
CRBG has the edge over BLK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $185M |
| Q2 2026 | $300M |
| Q1 2026 | $1.3B |
| Q4 2025 | $1.1B |
| Q3 2025 | $380M |
| Q2 2025 | $311M |
| Q1 2025 | $321M |
| Q4 2024 | $398M |
CRBG spent $2.8B buying back its own shares over the past year, up 101% from the year before.
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has the edge over CRBG on leverage, with a lower net debt burden relative to earnings.
CRBG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | 360.7x | High |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 1.9x | Healthy |
CRBG's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like CRBG.
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
CRBG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.8 | Neutral |
| Stochastic | 72.5 | Neutral |
CRBG's weekly RSI is 66 (neutral) and its Stochastic is 73 (neutral).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
CRBG PE vs Financial Services Sector
| Metric | CRBG | Sector median | Relative |
|---|---|---|---|
| PE | 8x | 13x | 39% below |
| PE % | 29 | 57 | 28 pts below |
CRBG has the edge over BLK on valuation relative to its sector.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK is in an uptrend: it's above all five of its weekly moving averages, and 33% above its 200-week average.
CRBG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.6 | 4.1% above |
| 20 week MA | $33.4 | 7.7% above |
| 50 week MA | $30.2 | 19% above |
| 100 week MA | $31.1 | 16% above |
| 200 week MA | $27.3 | 32% above |
CRBG is in an uptrend: it's above all five of its weekly moving averages, and 32% above its 200-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has finished higher in five of the last six years. It's up 12% so far in 2026.
CRBG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $20.7 | $20.3 | -2.2% |
| 2023 | $20.3 | $21.7 | +6.9% |
| 2024 | $21.7 | $30.0 | +39% |
| 2025 | $30.0 | $30.6 | +1.9% |
| 2026 YTD | $30.6 | $36.0 | +18% |
CRBG has the edge over BLK on returns for 2026, with the stronger performance.